腹水的管理:AJR专家小组叙述性综述
本文为AJR专家小组叙述性综述,基于现有证据与临床经验,为腹水的诊断和管理提供指导。血清-腹水白蛋白梯度是鉴别病因的主要诊断试验,治疗从大容量腹腔穿刺和隧道式腹膜导管置入到利尿剂、TIPS置入和淋巴管造影等靶向治疗。肝硬化腹水已有学会指南,其他少见病因所致腹水的管理仍不明确。
要点
- 血清-腹水白蛋白梯度是鉴别腹水病因的主要诊断试验。
- 治疗包括大容量腹腔穿刺、隧道式腹膜导管置入等非特异性液体移除。
- 靶向治疗包括利尿剂、TIPS置入和淋巴管造影。
核心结论
- 本综述旨在基于现有证据和作者临床经验,为腹水的诊断和管理提供指导。
研究设计与样本
- AJR专家小组叙述性综述,基于现有证据和作者临床经验提供指导。
诊断标准与关键数值
- 血清-腹水白蛋白梯度是鉴别腹水病因的主要诊断试验,并根据临床怀疑进行某些额外的液体检查。
- 肝硬化腹水已有学会指南,其他少见病因所致腹水的管理仍不明确。
局限性
- 其他少见病因所致腹水的管理仍不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Ascites can develop in the setting of a variety of pathologies. The approach to treatment depends on accurate determination of the underlying cause, for which fluid analysis plays a central role. In particular, the serum-ascites albumin gradient serves as a primary diagnostic test for differentiating among causes, with certain additional fluid tests performed based on clinical suspicion. Treatment options range from nonspecific fluid removal, including large-volume paracentesis and placement of tunneled peritoneal catheters, to targeted therapies (e.g., diuretics, TIPS placement, and lymphangiography). Societal guidelines exist for the approach to cirrhotic ascites, but the management of ascites due to other less common causes remains less well defined. The goal of this AJR Expert Panel Narrative Review is to provide guidance for the diagnosis and management of ascites, based on available evidence and our clinical experience.
引用
- Cornman-Homonoff J, Fortune BE, Kolli KP, et al. Management of Ascites: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2026. PMID: 40202355. doi:10.2214/AJR.23.30768
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。